MedTrace Logo

Kidney Cancer DNA Registry

NCT02087852 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2026-04-09

No results posted yet for this study

Summary

This registry will help us develop better methods of:

* Preventing these cancers
* Diagnosing these cancers
* Treating these cancers

Conditions

  • Renal Cancer

Interventions

OTHER

salvia for germline DNA

BEHAVIORAL

the Kidney Cancer Questionnaire

Patients will complete the appropriate surveys on either paper or on the computer/iPad in the office using REDCap software. If patients are unable to complete their questionnaires at the time of their in-office visit, a link to the questionnaires in REDCap will be emailed to them. The survey data that is collected in REDCap will be stored in REDCap. Clinic staff may also call patients to remind patients to complete questionnaires.

BEHAVIORAL

Family History Questionnaire (when applicable)

Patients will complete the appropriate surveys on either paper or on the computer/iPad in the office using REDCap software. If patients are unable to complete their questionnaires at the time of their in-office visit, a link to the questionnaires in REDCap will be emailed to them. The survey data that is collected in REDCap will be stored in REDCap. Clinic staff may also call patients to remind patients to complete questionnaires.

OTHER

Blood draw

BEHAVIORAL

Epidemiologic Questionnaire

Patients will complete the appropriate surveys on either paper or on the computer/iPad in the office using REDCap software. If patients are unable to complete their questionnaires at the time of their in-office visit, a link to the questionnaires in REDCap will be emailed to them. The survey data that is collected in REDCap will be stored in REDCap. Clinic staff may also call patients to remind patients to complete questionnaires.

Sponsors & Collaborators

Principal Investigators

  • Jonathan Jonathan, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02087852 on ClinicalTrials.gov